White paper: Mapping the future of the supply chain for specialty drugs

By Christopher Engel |

Market success in the pharmaceutical industry is dependent on a multitude of often competing factors. As patients’ expectations and care needs, payer requirements and the regulatory environment evolve, so do marketing, launch and supply strategies. And in an environment so tightly bound by cost containment measures, logistics has been the least regarded area; often planned late, if at all, prone to local regulatory vagaries and squeezed into pre-existing business models.

In this paper we look at potential solutions to create a better supply chain model for the future. Our consultations with leading pharmaceutical stakeholders have highlighted the key challenges and their potential solutions. The continued discussions around, and adoption of, these solutions will ease the transition from existing business models that do not meet the needs of supply or demand, to a system that facilitates the new pharmaceutical landscape.


About the Author

A portrait of Christopher Engel.

Christopher Engel

Product Manager - Commercial Supply Chain NCEE
World Courier

Chris Engel has a strong background in logistics and has intercultural working experiences in China and Switzerland.

Since 2008 Chris held several sales responsibilities and roles in logistics, has been handling major worldwide accounts at TNT Express and FedEx, and also has experience in managing global pharmaceutical clients at World Courier as a Global Account Manager.

During his time in World Courier since 2014, Chris worked on and has lead numerous projects for high value specialty drugs and shipments of exceptional sensitivity, low tolerance to temperature deviations and challenging time requirements. He has been using his expertise to manage and design complex supply chains for both worldwide clinical trials and commercial drugs.

As a Product Manager for Commercial Supply Chain being responsible for Northern, Central and Eastern Europe in World Courier, Chris is helping clients with the transition from clinical to commercial drug logistics, including product launch, drugs with volatile demand and all volumes from single dosages to bulk shipments.

View Bio